28 Jan 2021
Patients with type 2 diabetes who take the diabetes drug, metformin, may have a threefold decrease in mortality risk from COVID-19, according to a study published in Frontiers in Endocrinology.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024